← Leaderboards
Matthew Alcusky
Univ Of Massachusetts Med Sch Worcester
$3,185,548
Attributed
$3,585,547
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $797.8K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,785,548 · 2
AHRQ$799,999 · 1
By mechanism
R01$3,124,922 · 2
R21$460,625 · 1
Top collaborators
- Jennifer Tjia2 shared
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Jerry H Gurwitz$26,233,444
- Kate L Lapane$19,502,306
- Becky A Briesacher$3,749,819
- Jennifer Tjia$9,280,382
- Terry S Field$2,167,342
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposHospitalizationAgedEligibility DeterminationEvidence BaseHigh RiskCharacteristicsCrosslinkData SourcesElderlyCognitive FunctionComorbidityCommunitiesFall RiskData SetAcuteEventCognitiveAmericanClinical TrialsDecision MakingEffectivenessCaringImpaired Cognition
Grant awards (7)
Impact of New Hospice Drug Policies on Expenditures, Utilization, Prescribing Quality, and Access$399,999
R01 · FY2025 · HS
Impact of New Hospice Drug Policies on Expenditures, Utilization, Prescribing Quality, and Access$400,000
R01 · FY2024 · HS
Antidementia medication use, safety, and effectiveness among nursing home residents with Alzheimer's disease$786,972
R01 · FY2022 · AG · contact PI
Antidementia medication use, safety, and effectiveness among nursing home residents with Alzheimer's disease$797,835
R01 · FY2021 · AG · contact PI
Antidementia medication use, safety, and effectiveness among nursing home residents with Alzheimer's disease$740,116
R01 · FY2020 · AG · contact PI
Anticoagulant Use, Safety, and Effectiveness for Ischemic Stroke Prevention in Nursing Home Residents with Atrial Fibrillation$209,375
R21 · FY2019 · AG · contact PI
Anticoagulant Use, Safety, and Effectiveness for Ischemic Stroke Prevention in Nursing Home Residents with Atrial Fibrillation$251,250
R21 · FY2018 · AG · contact PI